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INTRODUCTION
Lymph nodes (LNs) draining a tumor may enlarge due to metastasis (LNM) or reactive hyperplasia. [1] The LNM can be used to calculate lymph node ratio (LNR) i.e., ratio of LNM to lymph node harvest (LNH). Reactive hyperplasia patterns consist of lymphocyte predominance (I), germinal center predominance (II), sinus histiocytosis (III), vascular transformation of sinuses (IV), lymphocyte depletion (V), and granulomatous reaction (VI). [2] The routine inclusion of LNR and LN reactive patterns in tumor reporting by pathologists may become a prognostic aid for clinicians alongside tumor stage and tumor grade.
Aims and objectives 1. To measure total LNH, LNM, and LNR in resected specimens of primary organ malignancy 2. To study LN reactive hyperplasia patterns 3. To evaluate LNR with tumor stage, tumor grade, LN reactive patterns, and LN size.
RESULTS

Distribution as per primary organ, gender, and age
There were 47, 20, 13, and 20 cases each of breast, gastrointestinal tract (GIT), genitourinary tract (GUT), and head, face, neck, and thyroid (HFNT) malignancy. GIT cases included colon (15) , stomach (2) , rectum (2) , and periampullary region (1) . GUT cases included urinary bladder (11) , ovary (1) , and vulva (1) . HFNT cases included buccal mucosa (11) , tongue (6) , and thyroid (3).
There was a marked female preponderance (64) over males (36), especially in breast (93.6%) and GUT cases (53.8%), with male predominance in GIT (70%) and HFNT cases (65%) (P < 0.001 LNH and LNM [ Table 1 ], total 1463 LNs were harvested from 100 cases. HFNT (23.7) and GIT (6.6) had the highest and lowest LNH, respectively (P = 0.008). LNM were observed in 257 LNs (54 cases), namely breast (28.6%), GIT (20.6%), GUT (9.3%), and HFNT (2.5%) (P = 0.595).
Lymph node immune hyperplasia patterns as per primary organ malignancy [Graph 3]
Overall, pattern III was the commonest (60) followed by pattern
MATERIALS AND METHODS
Total 108 resection cases of primary organ malignancy with local LN clearance were found as per archival records in a retrospective 1-year study. Slides and blocks of 8 cases were unavailable and hence total 100 cases were included in this study. Age, gender, tumor stage of primary organ malignancy, total LNs dissected per case, and LN sizes were accessed from surgical histopathology records. Slides were reviewed to evaluate LNM and LNR was calculated per specimen.
LN reactive hyperplasia was categorized into following morphological patterns: [2] • Pattern I (lymphocyte predominance) [ Figure 1a (17), pattern VI (6), and pattern V (3) (P = 0.000). A mixed pattern was observed in 48 cases, commonest combination being pattern II and III (21) . The commonest combination of pattern I was with pattern II (15) that of pattern IV was with pattern I (7), and of pattern VI was with pattern II (5).
Stage and grade of primary organ tumor [Graphs 4 and 5]
There were 20, 47, 26, and 7 cases, respectively, in tumor stage T1, T2, T3, and T4. Maximum cases of breast (59.6%), GUT (53.8%), and HFNT (45%) belonged to T2 stage, while GIT (60.0%) Graph 3: Distribution of lymph node immune reactivity patterns as per primary organ malignancy (n = 100) Graph 1: Gender distribution of cases as per primary organ of malignancy (n = 100) belonged to T3 (P = 0.000). Distribution as per tumor grade showed well-differentiated (22) , moderately differentiated (68), and poorly differentiated (10) cases. Maximum well-differentiated cases belonged to HFNT (13, 59 .0%), while maximum moderately differentiated and poorly differentiated to breast (38, 55.8%) and (7, 70 .0%), respectively (P = 0.000). Maximum total cases showing nodal metastases were moderately differentiated (77.8%) and belonged to stage T2 (48.1%).
Primary organ cases, T stage, and lymph node ratio [ Table 2 ] Mean calculated LNR for breast was 0.29 (range 0.0-1.0), for GIT was 0.26 (0.0-1.0), for GUT was 0.1 (0.0-0.56), and for HFNT 0.06 (0.0-0.67) (P = 0.8617). Majority breast, GUT, and HFNT cases below and above the mean LNR belonged to stage T2 (P = 0.92, P = 0.098, and P = 0.93, respectively). Majority GIT cases below and above the mean LNR belonged to stage T3 (P = 0.32).
Primary organ cases, lymph node reactive pattern, and lymph node ratio [ Table 3 ] Overall, pattern III was the commonest (60) followed by pattern II (46), pattern I (31), pattern IV (17), pattern VI (6), and pattern V (3) (P = 0.000). Total 82 LN reactive patterns were seen in 47 breast cases. Majority breast cases with LNR <0.3 (20) showed pattern II while those with LNR > 0.3 (10) showed pattern III (P = 0.56). Total 32 LN reactive patterns were seen in 20 GIT cases, of which pattern III (10 and 4, respectively) was the commonest irrespective of mean LNR cut-off (P = 0.54). Total 21 LN reactive patterns were seen in 13 GUT cases, of which Primary organ cases, lymph node reactive pattern, and T stage [ Table 4 ] Amongst breast cases, patterns I-IV and VI were highest in stage T2, while pattern V in T1 stage (P = 0.92). In GIT cases, patterns I-III and VI were highest in stage T3, while pattern IV was equally distributed in T2 and T3 (P = 0.74). Amongst GUT cases, patterns II, III, and V were commonest in stage T2, pattern I was equal in T1 and T2, pattern IV in T1, and pattern VI in T4 (P = 0.78). In HFNT cases, patterns I and II were equally distributed in stages T1 and T2 while patterns III-VI were highest in T1 (P = 0.97).
Lymph node size
The largest metastatic node measured 2.1 cm and 2.4 cm in breast and GUT (P = 0.009 and 0.039, respectively) while 1.2 cm and 2.3 cm for GIT and HFNT (P = 0.463 and 0.163, respectively). The smallest metastatic node measured 0.4 cm. Negative nodes (46 cases) varied from 0.1-3.0 cm.
Other findings
Metastases were observed in 28 cases (75.7%) with thickened LN capsule [ Figure 5a and b] and in only 26 cases (41.3%) with normal capsule (P = 0.003871). Twelve cases showed extranodal tumor deposits, of which 9 (75%) belonged to T2 and T3 stage.
DISCUSSION
The present study evaluated LNM, LNR, and LN reactive patterns from primary organ malignancies resected with local nodal clearance. LNH, LNM, LNR, and LN patterns were studied for correlation with tumor stage and tumor grade. [6] whereas we found a female preponderance. The male predominance in GIT and HFNT malignancies may reflect lifestyle-related behavior as alcoholism, processed junk food, smoking, and tobacco chewing. The peak age groups of malignancy were a decade younger compared to other studies. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Lymph node harvested The recommended LNH values are 10, 12, 12, and 40 in breast, GIT, GUT, and HFNT, respectively. [13] [14] [15] [16] It varies from 10 to [8, 13] and 18.5 to 28 in colorectal cancers. [4, 14] Koppie et al. found values 7.5, 8.6, and 14.7 in pelvic cancers over three decades. [17] Mean LNH for oropharyngeal cancers varies from 9 to 18 [10] and 7.9 to 20 [11, 12] for thyroid cancers. Techniques to further improve the yield of LNH include meticulous dissection during grossing, intratumoral India ink injection during surgery, ex-vivo intra-arterial injection of methylene blue, and chemical fat clearance using acetone and alcohol. [15, 18] Lymph node metastases Titipungul et al. found mean LNM of 3.2 in breast cases, while Freneaux et al. found 47.3% LNM. [8, 13] Mean LNM was 1-6 in GIT cases, [4, 14] 0.2 and 45.5% in urinary bladder malignancies, [9, 17] 70 and 58% in oral cancers, [5, 10] and 4.5-10 in papillary thyroid carcinoma. [11, 19] Serial recuts, use of immunohistochemistry, one step nucleic acid amplification (OSNA), and polymerase chain reaction can further aid in detecting minute nodal metastases. [20] [21] [22] Lymph node reactive patterns Khetarpal et al. found pattern I (0.4%), pattern II (23.7%), pattern III (12.3%), and mixed patterns (25.7%) in breast cancers. [23] Ninan et al. found pattern II commonest (32) while pattern V (1) rarest in colorectal cancers. [24] They found the commonest combination patterns as II + IV, II + III, and II + I (17, 14, 9, respectively). [24] Suchitra et al. found pattern I (53.49%), pattern II (31.5%), and pattern V (4.6%) oral cancers. [10] Tumor stage and tumor grade Titipungul et al. found majority of breast malignancy cases (55.7%) in T2 stage and 32% moderately differentiated. [13] Khetarpal et al. found 76% moderately differentiated, 18% well differentiated, and 6% poorly differentiated breast cases. [23] Dedavid et al. found 82% of colorectal cancers in stage T3/T4 and 61% belonging to well/moderately differentiated group. [14] Akagi et al. found a recurrence rate of 64.9% for T3 colorectal carcinomas. [4] Most urinary bladder malignancies were reported in stage T3 (37 and 41.3%). [9, 17] Suchitra et al. found 40% oral malignancies in T4 stage. [10] Breast cases lymph node ratio, T stage, and lymph node reactive pattern Titipungul et al. found LNR had a higher predictive value than N stage. [13] They classified breast cancers as low risk (LNR 0.01-0.2), intermediate risk (LNR 0.21-0.65), and high risk (LNR 0.66-1.0) with the 5-year survival being 66.7%, 50%, and 0.0%, respectively. [13] Our cases qualify as intermediate risk LNR and showed high tumor grade. Khetarpal et al. found pattern III associated with high tumor grade and nodal metastases in breast. [23] Gastrointestinal cases lymph node ratio, T stage, and lymph node reactive patterns Dedavid et al. found mean LNR 0.15 as the best predictor of recurrence in colon cancer. [14] We observed higher LNR, possibly due to lowest LNH yield as also related to majority cases being in stage T3. Akagi et al. found recurrence rate of 64.9% in stage T3 in colon cancers. [4] Ninan et al. found pattern I commonest in non-metastatic cases and high tumor grade. [24] Zeng et al. found LNR to have high prognostic value in gastric cancers using cut-off points as 0, 0.5, and 0.8 to categorize low, intermediate, and high risk. [3] Genitourinary cases lymph node ratio, T stage, and lymph node reactive patterns Rubinstein et al., Wright et al., and Pedrosa et al. used 2.4, 0.12, and 0.2 LNR cut-off, respectively, for urinary bladder malignancies. [6, 9, 16] Wright et al. found higher LNR (12.6-25%) associated with higher risk of death, [9] while Pedrosa et al. found stage T2 significantly associated with LNH. [16] Head, face, neck, and thyroid cases lymph node ratio, T stage, and lymph node reactive patterns Chen et al. categorized head and neck cancers as low LNR <0.06, medium 0.06-0.17, and high LNR >0.17. [5] They found low LNR to have longer 3-year survival and metastasis-free survival. [5] They found 71.7% cases in stage T4 and LNM was 53.8%. [5] Our cases qualify as low LNR, had highest LNH, and were predominantly low grade tumors. Vered et al. found 87.5% of non-metastatic nodes and 63.5% metastatic nodes in stage T1 and T2. [18] Suchitra et al. found positive nodes showing pattern II (18.9%), pattern III (23.5%), and pattern IV (54.4%). [10] Lang et al. classified papillary thyroid carcinoma having LNR value 0.0-0.33, 0.34-0.66, and 0.67-1.0. [11] LNR was associated with higher rate of post-ablative thyroglobulin levels and higher recurrence rate. (n=47)  T1  3 5  3  1  1  0  T2  9 18 17 5  0  3  T3  3 3  6  2  0  1  T4  0 Lymph node metastases versus lymph node size Märkl et al. found 49.5% LNM in nodes <0.5 cm and 25% in >1.0 cm of colon cancers. [15] Burusapat et al. found mean size of positive nodes as 0.3 cm in oral cancers. [25] We observed metastases in small LNs up to 0.4 cm, while even LNs up to 3.0 cm showed non-metastatic reactive hyperplasia.
Gender and age-wise distribution of cases
Additional lymph node findings
As in our study, Vered et al. found LN capsule thickness positively associated with LNM. [18] CONCLUSIONS Nodal metastases can co-exist with reactive hyperplasia. LNH and LNR cut-off values show organ-wise variation, hence need standardization before their usage in cancer staging systems. LNR showed stronger relation with tumor grade than with tumor stage. Commonest LN reactive patterns included sinus histiocytosis and follicular hyperplasia, irrespective of nodal metastases. In breast and GUT cases, pattern changed from II (humoral) to III (cellular) with higher T stage while the reverse was observed in HFNT, although not statistically significant. Thickened LN capsule is strongly suggestive of nodal metastases. A longitudinal follow-up study is warranted to confirm prognostic association, if any, for LNR and LN reactive pattern.
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